Memorial Sloan Kettering Cancer Center researchers have found RNA neoantigen vaccines that generate long-lived, functional ...
Allogene Therapeutics published new long-term follow-up data on cemacabtagene ansegedleucel, showing the investigative ...
Explore how T cell engagers could transform cancer and autoimmune treatments through promising trials and key collaborations.
A person with neuroblastoma, which occurs when developing nerve cells in children turn cancerous, has remained tumour-free ...
CAR T-cell therapy for cancer leads to similar safety and cancer outcomes in patients with and without preexisting autoimmune ...
CAR-T-cell therapy treated a girl with a rare childhood cancer, raising hopes for future recipients of the approach.
Therapy timing, patient factors, and emerging combination interventions are guiding treatment decisions in multiple myeloma and lymphoma.
During a Case-Based Roundtable® event, Natalie Galanina, MD, discussed data from the ZUMA-7 and TRANSFORM trials in the first ...
The addition of itacitinib to standard graft-versus-host-disease prophylaxis may reduce severe toxicities following ...
An 18-year survivor of neuroblastoma, a solid childhood tumor that develops in immature nerve cells, is believed to represent ...
Swarm Oncology Ltd., a biotechnology company, has partnered with Cellex Cell Professionals GmbH, a contract development and ...
Wānaka resident and multiple myeloma blood cancer patient Emma Holden, 36, will soon travel to Shanghai, China for ...